 Daniel Frank
Concepts (758)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 40 | 2023 | 683 | 6.210 |
Why?
| | Gastrointestinal Microbiome | 42 | 2023 | 557 | 5.420 |
Why?
| | Sinusitis | 17 | 2023 | 171 | 5.290 |
Why?
| | Rhinitis | 15 | 2022 | 128 | 5.250 |
Why?
| | Bacteria | 34 | 2023 | 767 | 3.480 |
Why?
| | RNA, Ribosomal, 16S | 47 | 2023 | 524 | 3.380 |
Why?
| | Metagenome | 15 | 2019 | 127 | 3.310 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 65 | 2.540 |
Why?
| | Intestines | 15 | 2022 | 337 | 2.360 |
Why?
| | Dysbiosis | 16 | 2023 | 151 | 2.200 |
Why?
| | Otitis Media | 7 | 2023 | 154 | 2.080 |
Why?
| | Feces | 22 | 2023 | 402 | 1.740 |
Why?
| | Intestinal Mucosa | 19 | 2020 | 543 | 1.700 |
Why?
| | RNA, Bacterial | 12 | 2018 | 176 | 1.680 |
Why?
| | Nasal Polyps | 5 | 2021 | 42 | 1.580 |
Why?
| | Nose | 4 | 2018 | 59 | 1.510 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 400 | 1.490 |
Why?
| | Nasal Cavity | 6 | 2023 | 50 | 1.400 |
Why?
| | Ileum | 5 | 2020 | 102 | 1.330 |
Why?
| | Bacteremia | 6 | 2018 | 166 | 1.310 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 767 | 1.290 |
Why?
| | Crohn Disease | 6 | 2020 | 207 | 1.230 |
Why?
| | Phylogeny | 24 | 2020 | 823 | 1.220 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 347 | 1.160 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 175 | 1.150 |
Why?
| | Chronic Disease | 17 | 2022 | 1684 | 1.060 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 30 | 0.950 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 43 | 0.930 |
Why?
| | Clostridium Infections | 4 | 2018 | 61 | 0.900 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 32 | 0.900 |
Why?
| | Endoribonucleases | 8 | 2002 | 74 | 0.840 |
Why?
| | HIV Infections | 13 | 2022 | 2588 | 0.840 |
Why?
| | Biodiversity | 13 | 2020 | 382 | 0.830 |
Why?
| | Humans | 126 | 2023 | 125131 | 0.830 |
Why?
| | Bacterial Infections | 3 | 2015 | 238 | 0.820 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 5 | 0.820 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 298 | 0.810 |
Why?
| | Cholesteatoma | 1 | 2022 | 14 | 0.800 |
Why?
| | Breast Feeding | 6 | 2023 | 394 | 0.800 |
Why?
| | Inflammation Mediators | 3 | 2023 | 515 | 0.780 |
Why?
| | RNA, Catalytic | 7 | 2001 | 183 | 0.770 |
Why?
| | Database Management Systems | 2 | 2013 | 58 | 0.740 |
Why?
| | Drinking Water | 1 | 2022 | 72 | 0.730 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.730 |
Why?
| | Inflammation | 12 | 2023 | 2612 | 0.720 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.720 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 100 | 0.710 |
Why?
| | User-Computer Interface | 2 | 2013 | 171 | 0.700 |
Why?
| | Software | 3 | 2021 | 647 | 0.700 |
Why?
| | Colon | 8 | 2023 | 243 | 0.690 |
Why?
| | Molecular Sequence Data | 26 | 2015 | 2926 | 0.680 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 125 | 0.670 |
Why?
| | Male | 60 | 2023 | 60792 | 0.660 |
Why?
| | Polymerase Chain Reaction | 9 | 2018 | 1042 | 0.650 |
Why?
| | Female | 69 | 2023 | 64889 | 0.650 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.650 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 108 | 0.630 |
Why?
| | Iron | 3 | 2017 | 236 | 0.630 |
Why?
| | Nasopharynx | 4 | 2022 | 67 | 0.620 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 423 | 0.620 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 157 | 0.610 |
Why?
| | Animals | 51 | 2023 | 34345 | 0.590 |
Why?
| | Genes, rRNA | 3 | 2015 | 39 | 0.590 |
Why?
| | Fatty Liver | 2 | 2021 | 256 | 0.570 |
Why?
| | Vagina | 5 | 2016 | 176 | 0.570 |
Why?
| | Adult | 38 | 2023 | 33167 | 0.560 |
Why?
| | Membrane Proteins | 3 | 2021 | 1089 | 0.550 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 482 | 0.550 |
Why?
| | Pharynx | 1 | 2016 | 55 | 0.540 |
Why?
| | Middle Aged | 34 | 2023 | 29112 | 0.540 |
Why?
| | Case-Control Studies | 15 | 2020 | 3326 | 0.530 |
Why?
| | Nose Diseases | 1 | 2016 | 11 | 0.530 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 16 | 0.530 |
Why?
| | Biofilms | 5 | 2016 | 234 | 0.520 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 286 | 0.520 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 131 | 0.500 |
Why?
| | Base Sequence | 18 | 2015 | 2207 | 0.500 |
Why?
| | Immunity, Innate | 4 | 2019 | 759 | 0.500 |
Why?
| | Mice | 26 | 2023 | 15984 | 0.500 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 74 | 0.490 |
Why?
| | HIV-1 | 7 | 2022 | 787 | 0.480 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 4854 | 0.480 |
Why?
| | Endotoxemia | 2 | 2014 | 94 | 0.480 |
Why?
| | Food | 2 | 2020 | 165 | 0.480 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 117 | 0.480 |
Why?
| | Hippocampus | 1 | 2018 | 756 | 0.470 |
Why?
| | Genome, Bacterial | 4 | 2016 | 111 | 0.460 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 47 | 0.450 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 176 | 0.440 |
Why?
| | Computer Graphics | 1 | 2013 | 49 | 0.440 |
Why?
| | Lactobacillus | 4 | 2022 | 29 | 0.440 |
Why?
| | Lipid Metabolism | 2 | 2020 | 485 | 0.440 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 312 | 0.430 |
Why?
| | Immunoglobulin A | 4 | 2022 | 176 | 0.430 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 86 | 0.430 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2023 | 135 | 0.430 |
Why?
| | Iron, Dietary | 1 | 2013 | 19 | 0.430 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 195 | 0.430 |
Why?
| | Liver | 4 | 2020 | 1872 | 0.420 |
Why?
| | Infant Food | 1 | 2013 | 63 | 0.420 |
Why?
| | Bacterial Load | 1 | 2012 | 69 | 0.410 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1559 | 0.400 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 194 | 0.400 |
Why?
| | Genitalia, Female | 1 | 2012 | 42 | 0.400 |
Why?
| | Probiotics | 5 | 2018 | 52 | 0.400 |
Why?
| | Smoking | 2 | 2020 | 1635 | 0.400 |
Why?
| | Diet | 7 | 2023 | 1178 | 0.390 |
Why?
| | Diet, High-Fat | 3 | 2019 | 251 | 0.390 |
Why?
| | Mice, Inbred C57BL | 14 | 2022 | 5102 | 0.390 |
Why?
| | Genomics | 4 | 2020 | 726 | 0.370 |
Why?
| | Asthma | 2 | 2015 | 2150 | 0.370 |
Why?
| | Livestock | 1 | 2010 | 6 | 0.370 |
Why?
| | Obesity | 7 | 2023 | 2805 | 0.370 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 160 | 0.360 |
Why?
| | Computational Biology | 3 | 2019 | 616 | 0.360 |
Why?
| | Stress, Psychological | 1 | 2018 | 1044 | 0.360 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 23 | 0.360 |
Why?
| | Ear, Middle | 5 | 2023 | 95 | 0.360 |
Why?
| | Weight Loss | 3 | 2021 | 677 | 0.360 |
Why?
| | Fucosyltransferases | 2 | 2022 | 31 | 0.350 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 10 | 0.350 |
Why?
| | Escherichia coli | 9 | 2017 | 766 | 0.350 |
Why?
| | Bacterial Translocation | 4 | 2019 | 37 | 0.350 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 18 | 0.350 |
Why?
| | DNA Primers | 3 | 2009 | 545 | 0.350 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2012 | 301 | 0.350 |
Why?
| | Arthritis, Experimental | 2 | 2023 | 130 | 0.340 |
Why?
| | Agriculture | 1 | 2010 | 95 | 0.340 |
Why?
| | Fluoroquinolones | 1 | 2009 | 43 | 0.340 |
Why?
| | Genome | 2 | 2009 | 290 | 0.340 |
Why?
| | Catheterization | 2 | 2009 | 161 | 0.330 |
Why?
| | Burns | 2 | 2023 | 254 | 0.330 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1001 | 0.330 |
Why?
| | Corynebacterium | 4 | 2022 | 37 | 0.330 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 33 | 0.330 |
Why?
| | Butyrates | 2 | 2021 | 55 | 0.320 |
Why?
| | Behavior Therapy | 2 | 2021 | 254 | 0.320 |
Why?
| | Wound Infection | 1 | 2009 | 32 | 0.320 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 2 | 0.310 |
Why?
| | Transcriptome | 5 | 2021 | 801 | 0.310 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 870 | 0.310 |
Why?
| | Milk, Human | 4 | 2023 | 146 | 0.310 |
Why?
| | Confidentiality | 1 | 2008 | 69 | 0.310 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 161 | 0.310 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 12 | 0.300 |
Why?
| | DNA, Bacterial | 6 | 2017 | 321 | 0.300 |
Why?
| | Fatty Acids, Volatile | 5 | 2019 | 48 | 0.300 |
Why?
| | Video Recording | 1 | 2008 | 169 | 0.290 |
Why?
| | Aged | 16 | 2023 | 20859 | 0.290 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 37 | 0.290 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 289 | 0.290 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 85 | 0.290 |
Why?
| | Genes, Bacterial | 5 | 2018 | 163 | 0.280 |
Why?
| | RNA, Transfer | 3 | 1998 | 119 | 0.280 |
Why?
| | Homeostasis | 5 | 2020 | 605 | 0.280 |
Why?
| | Congresses as Topic | 1 | 2008 | 215 | 0.280 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3471 | 0.280 |
Why?
| | Perilipin-2 | 2 | 2017 | 36 | 0.270 |
Why?
| | Dietary Supplements | 3 | 2019 | 478 | 0.270 |
Why?
| | Infant | 14 | 2023 | 8625 | 0.270 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 680 | 0.270 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 57 | 0.270 |
Why?
| | Carrier Proteins | 1 | 2010 | 743 | 0.270 |
Why?
| | Neoplasms | 2 | 2018 | 2340 | 0.270 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1077 | 0.260 |
Why?
| | Disease Models, Animal | 6 | 2022 | 3823 | 0.260 |
Why?
| | Genotype | 4 | 2019 | 1960 | 0.260 |
Why?
| | Public Health | 1 | 2010 | 493 | 0.260 |
Why?
| | Diet, Western | 3 | 2022 | 70 | 0.260 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 86 | 0.250 |
Why?
| | DNA, Ribosomal | 6 | 2017 | 82 | 0.250 |
Why?
| | Phenotype | 8 | 2020 | 3153 | 0.250 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 582 | 0.250 |
Why?
| | Research | 1 | 2008 | 440 | 0.250 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 468 | 0.240 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 180 | 0.240 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 374 | 0.240 |
Why?
| | Construction Materials | 2 | 2015 | 15 | 0.240 |
Why?
| | Pedigree | 3 | 2020 | 506 | 0.240 |
Why?
| | Cohort Studies | 7 | 2022 | 5348 | 0.240 |
Why?
| | Air Microbiology | 2 | 2015 | 41 | 0.230 |
Why?
| | Infant Formula | 2 | 2023 | 84 | 0.220 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 21 | 0.220 |
Why?
| | Young Adult | 12 | 2021 | 11384 | 0.220 |
Why?
| | RNA Splicing | 3 | 1995 | 254 | 0.220 |
Why?
| | Colitis | 3 | 2020 | 226 | 0.220 |
Why?
| | RNA, Fungal | 5 | 2002 | 69 | 0.210 |
Why?
| | Ear Canal | 1 | 2003 | 16 | 0.210 |
Why?
| | Sepsis | 2 | 2023 | 563 | 0.210 |
Why?
| | Species Specificity | 4 | 2020 | 592 | 0.210 |
Why?
| | Ribonuclease P | 7 | 2001 | 25 | 0.210 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 18 | 0.210 |
Why?
| | Gene Ontology | 1 | 2022 | 57 | 0.210 |
Why?
| | Adolescent | 12 | 2021 | 19411 | 0.200 |
Why?
| | Fungal Proteins | 2 | 2000 | 132 | 0.200 |
Why?
| | Olfaction Disorders | 1 | 2023 | 53 | 0.200 |
Why?
| | Disease Susceptibility | 3 | 2020 | 343 | 0.200 |
Why?
| | Genetic Variation | 4 | 2018 | 970 | 0.200 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 8 | 0.200 |
Why?
| | Pregnancy | 9 | 2022 | 5922 | 0.200 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 997 | 0.200 |
Why?
| | Mycobacterium | 1 | 2023 | 105 | 0.200 |
Why?
| | Exome | 2 | 2020 | 229 | 0.200 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 97 | 0.200 |
Why?
| | Immunity | 2 | 2014 | 130 | 0.200 |
Why?
| | Haemophilus Infections | 1 | 2022 | 33 | 0.200 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 471 | 0.200 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 41 | 0.200 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 13 | 0.190 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 207 | 0.190 |
Why?
| | Nutritional Status | 2 | 2014 | 304 | 0.190 |
Why?
| | Genes, Fungal | 4 | 2000 | 52 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 216 | 0.190 |
Why?
| | Biomarkers | 7 | 2023 | 3736 | 0.190 |
Why?
| | Toxins, Biological | 1 | 2020 | 16 | 0.180 |
Why?
| | Health | 2 | 2012 | 80 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 511 | 0.180 |
Why?
| | Ascomycota | 1 | 2000 | 27 | 0.180 |
Why?
| | Body Mass Index | 5 | 2020 | 2174 | 0.180 |
Why?
| | Islets of Langerhans | 3 | 2015 | 745 | 0.180 |
Why?
| | Aged, 80 and over | 6 | 2021 | 6936 | 0.180 |
Why?
| | Ear, External | 1 | 2020 | 26 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 35 | 0.180 |
Why?
| | Carcinogenesis | 1 | 2022 | 186 | 0.180 |
Why?
| | Mucin 5AC | 1 | 2020 | 47 | 0.180 |
Why?
| | Mice, Knockout | 5 | 2022 | 2736 | 0.180 |
Why?
| | Firmicutes | 2 | 2021 | 20 | 0.180 |
Why?
| | Mice, Nude | 1 | 2022 | 673 | 0.180 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.180 |
Why?
| | Mouth | 1 | 2020 | 80 | 0.180 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.170 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 96 | 0.170 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 10 | 0.170 |
Why?
| | Vascular Remodeling | 1 | 2021 | 160 | 0.170 |
Why?
| | Autoimmunity | 3 | 2015 | 835 | 0.170 |
Why?
| | Bacteroides | 1 | 2019 | 18 | 0.170 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.170 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 9 | 0.170 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 58 | 0.160 |
Why?
| | Child | 10 | 2023 | 20014 | 0.160 |
Why?
| | Vitamin B Complex | 1 | 2019 | 38 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 244 | 0.160 |
Why?
| | Child, Preschool | 8 | 2023 | 9938 | 0.160 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 1904 | 0.160 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 158 | 0.160 |
Why?
| | Oxonic Acid | 1 | 2018 | 13 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 340 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2020 | 305 | 0.160 |
Why?
| | Restraint, Physical | 1 | 2018 | 96 | 0.160 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2135 | 0.160 |
Why?
| | Organic Chemicals | 1 | 2020 | 132 | 0.160 |
Why?
| | Vitamin B 12 | 1 | 2019 | 116 | 0.160 |
Why?
| | Microbiological Techniques | 2 | 2016 | 32 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Rats | 8 | 2023 | 5517 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 93 | 0.150 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 14 | 0.150 |
Why?
| | Evolution, Molecular | 2 | 2018 | 458 | 0.150 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 124 | 0.150 |
Why?
| | Spondylarthritis | 1 | 2018 | 36 | 0.150 |
Why?
| | Prospective Studies | 4 | 2020 | 6818 | 0.150 |
Why?
| | Random Allocation | 1 | 2018 | 377 | 0.150 |
Why?
| | Down Syndrome | 1 | 2023 | 403 | 0.150 |
Why?
| | Immunoglobulin D | 1 | 2017 | 28 | 0.150 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.150 |
Why?
| | Lung | 4 | 2022 | 3865 | 0.150 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 6 | 0.150 |
Why?
| | Birth Weight | 1 | 2020 | 477 | 0.150 |
Why?
| | Ethanol | 1 | 2022 | 735 | 0.150 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 173 | 0.150 |
Why?
| | Respiratory Sounds | 1 | 2018 | 120 | 0.150 |
Why?
| | Infant, Newborn | 4 | 2020 | 5456 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2018 | 107 | 0.140 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 97 | 0.140 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 32 | 0.140 |
Why?
| | Water Microbiology | 3 | 2016 | 77 | 0.140 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.140 |
Why?
| | Metals | 1 | 1997 | 116 | 0.140 |
Why?
| | Autoantibodies | 3 | 2022 | 1382 | 0.140 |
Why?
| | Ceftriaxone | 1 | 2016 | 21 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 134 | 0.140 |
Why?
| | Metabolome | 1 | 2020 | 307 | 0.140 |
Why?
| | beta-Lactamases | 1 | 2016 | 26 | 0.140 |
Why?
| | Micronutrients | 1 | 2017 | 82 | 0.140 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.140 |
Why?
| | Gene Expression | 2 | 2018 | 1528 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 69 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 2016 | 18 | 0.130 |
Why?
| | Vitamin E | 1 | 2016 | 116 | 0.130 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 55 | 0.130 |
Why?
| | Hospitalization | 3 | 2018 | 1960 | 0.130 |
Why?
| | Cholesterol | 3 | 2023 | 390 | 0.130 |
Why?
| | Symbiosis | 2 | 2017 | 65 | 0.130 |
Why?
| | Salmonella Infections | 1 | 2016 | 51 | 0.130 |
Why?
| | Gelatin | 1 | 2016 | 36 | 0.130 |
Why?
| | Bacillus | 1 | 2015 | 15 | 0.130 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 114 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 399 | 0.130 |
Why?
| | Binding Sites | 6 | 1998 | 1248 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2017 | 710 | 0.130 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 70 | 0.130 |
Why?
| | Metagenomics | 2 | 2019 | 135 | 0.130 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 8 | 0.130 |
Why?
| | RNA, Messenger | 4 | 2018 | 2753 | 0.130 |
Why?
| | Pneumonia | 1 | 2021 | 610 | 0.130 |
Why?
| | Antibiosis | 1 | 2015 | 7 | 0.130 |
Why?
| | Streptococcus mitis | 1 | 2015 | 8 | 0.130 |
Why?
| | Textiles | 1 | 2015 | 21 | 0.130 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 669 | 0.130 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 35 | 0.130 |
Why?
| | Double-Blind Method | 3 | 2017 | 1725 | 0.130 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 17 | 0.130 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 17 | 0.130 |
Why?
| | Thrombophilia | 1 | 2016 | 70 | 0.130 |
Why?
| | Catalase | 1 | 2015 | 127 | 0.130 |
Why?
| | Rectum | 1 | 2016 | 160 | 0.130 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 57 | 0.130 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 224 | 0.130 |
Why?
| | Lymph | 1 | 2015 | 42 | 0.130 |
Why?
| | Sanitary Engineering | 1 | 2015 | 6 | 0.130 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 34 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 78 | 0.120 |
Why?
| | Hysterectomy | 1 | 2016 | 118 | 0.120 |
Why?
| | Thrombin | 1 | 2016 | 146 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1992 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 61 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 332 | 0.120 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 78 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 177 | 0.120 |
Why?
| | Carrier State | 1 | 2015 | 57 | 0.120 |
Why?
| | Hypoxia | 1 | 2021 | 1021 | 0.120 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 83 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 144 | 0.120 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 80 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 484 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2382 | 0.120 |
Why?
| | Humidity | 1 | 2014 | 45 | 0.120 |
Why?
| | Gentamicins | 1 | 2015 | 43 | 0.120 |
Why?
| | Household Articles | 1 | 2014 | 23 | 0.120 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 110 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 233 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 101 | 0.120 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 988 | 0.120 |
Why?
| | Mucous Membrane | 1 | 2015 | 123 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 252 | 0.120 |
Why?
| | Physical Exertion | 1 | 2015 | 236 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 639 | 0.120 |
Why?
| | Bifidobacterium | 3 | 2022 | 22 | 0.120 |
Why?
| | Maternal Welfare | 1 | 2014 | 15 | 0.120 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 12 | 0.120 |
Why?
| | Adiposity | 2 | 2018 | 529 | 0.120 |
Why?
| | Biota | 1 | 2014 | 37 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 612 | 0.120 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 31 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 46 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 139 | 0.110 |
Why?
| | Preconception Care | 1 | 2014 | 33 | 0.110 |
Why?
| | Body Weight | 2 | 2015 | 959 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 38 | 0.110 |
Why?
| | Nutrition Assessment | 1 | 2014 | 81 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 1008 | 0.110 |
Why?
| | Cytokines | 4 | 2023 | 1927 | 0.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 67 | 0.110 |
Why?
| | Soil Microbiology | 1 | 2015 | 184 | 0.110 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.110 |
Why?
| | Consensus | 1 | 2016 | 577 | 0.110 |
Why?
| | Bacteroidetes | 3 | 2021 | 22 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2020 | 540 | 0.110 |
Why?
| | Gastric Bypass | 1 | 2014 | 94 | 0.110 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 215 | 0.110 |
Why?
| | Antibodies, Viral | 1 | 2016 | 561 | 0.110 |
Why?
| | Zinc Fingers | 1 | 1992 | 46 | 0.100 |
Why?
| | Burkina Faso | 1 | 2012 | 3 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1347 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 585 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 18 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 25 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 258 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2018 | 777 | 0.100 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 66 | 0.100 |
Why?
| | Skin | 1 | 2016 | 698 | 0.100 |
Why?
| | Aerosols | 1 | 2013 | 224 | 0.100 |
Why?
| | Influenza Vaccines | 1 | 2016 | 504 | 0.100 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 127 | 0.100 |
Why?
| | Genetics, Medical | 1 | 2011 | 26 | 0.100 |
Why?
| | Prenatal Care | 1 | 2014 | 277 | 0.100 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 745 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 524 | 0.100 |
Why?
| | Morphogenesis | 1 | 2012 | 171 | 0.100 |
Why?
| | Obesity, Morbid | 1 | 2014 | 204 | 0.090 |
Why?
| | Viruses | 1 | 2012 | 97 | 0.090 |
Why?
| | Lactation | 1 | 2012 | 173 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 785 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1379 | 0.090 |
Why?
| | Insulin | 2 | 2022 | 2219 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 357 | 0.090 |
Why?
| | Nutritive Value | 1 | 2010 | 30 | 0.090 |
Why?
| | Food Safety | 1 | 2010 | 18 | 0.090 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 48 | 0.090 |
Why?
| | Risk Factors | 4 | 2018 | 9549 | 0.090 |
Why?
| | Treatment Outcome | 5 | 2018 | 9790 | 0.090 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1300 | 0.090 |
Why?
| | Amphotericin B | 1 | 2010 | 33 | 0.090 |
Why?
| | Bacterial Capsules | 1 | 2010 | 29 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1880 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 717 | 0.090 |
Why?
| | Retrospective Studies | 4 | 2022 | 13708 | 0.090 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 28 | 0.090 |
Why?
| | Dextran Sulfate | 2 | 2020 | 71 | 0.090 |
Why?
| | Urinary Catheterization | 1 | 2009 | 27 | 0.090 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 71 | 0.090 |
Why?
| | Cluster Analysis | 3 | 2017 | 497 | 0.080 |
Why?
| | Prevalence | 2 | 2014 | 2488 | 0.080 |
Why?
| | Fatty Acids | 3 | 2022 | 414 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 85 | 0.080 |
Why?
| | Montana | 1 | 2009 | 16 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2017 | 1108 | 0.080 |
Why?
| | Prostatectomy | 1 | 2009 | 102 | 0.080 |
Why?
| | Mississippi | 1 | 2009 | 20 | 0.080 |
Why?
| | Biomass | 1 | 2009 | 130 | 0.080 |
Why?
| | Sequence Alignment | 3 | 2001 | 338 | 0.080 |
Why?
| | Permeability | 2 | 2022 | 155 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2236 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 664 | 0.080 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 141 | 0.080 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 93 | 0.080 |
Why?
| | Systems Integration | 1 | 2008 | 42 | 0.080 |
Why?
| | Environment | 1 | 2010 | 355 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 317 | 0.080 |
Why?
| | Housing | 1 | 2009 | 131 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2669 | 0.080 |
Why?
| | Prognosis | 2 | 2020 | 3616 | 0.080 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 145 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2013 | 699 | 0.080 |
Why?
| | RNA Precursors | 4 | 1998 | 143 | 0.080 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 72 | 0.080 |
Why?
| | Ecosystem | 2 | 2010 | 572 | 0.070 |
Why?
| | Child Development | 1 | 2012 | 426 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2492 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 37 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2010 | 317 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 133 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 220 | 0.070 |
Why?
| | Plasmids | 4 | 2016 | 361 | 0.070 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 192 | 0.070 |
Why?
| | Artificial Intelligence | 1 | 2008 | 158 | 0.070 |
Why?
| | Peptic Ulcer | 1 | 2006 | 15 | 0.070 |
Why?
| | Indomethacin | 1 | 2006 | 77 | 0.070 |
Why?
| | Research Personnel | 1 | 2008 | 166 | 0.070 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 25 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 533 | 0.070 |
Why?
| | Inpatients | 1 | 2010 | 414 | 0.070 |
Why?
| | Proteobacteria | 2 | 2017 | 17 | 0.070 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 27 | 0.070 |
Why?
| | Opportunistic Infections | 1 | 2006 | 48 | 0.070 |
Why?
| | Immunoglobulin G | 2 | 2022 | 808 | 0.070 |
Why?
| | Kenya | 2 | 2017 | 103 | 0.070 |
Why?
| | Autoantigens | 2 | 2022 | 406 | 0.070 |
Why?
| | Principal Component Analysis | 2 | 2017 | 192 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 135 | 0.060 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 990 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 15 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 895 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 19 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1996 | 566 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 679 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3047 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2005 | 318 | 0.060 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 325 | 0.060 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 95 | 0.060 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 62 | 0.060 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 68 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 180 | 0.060 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 150 | 0.060 |
Why?
| | Salmon | 1 | 2023 | 13 | 0.060 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 4 | 0.060 |
Why?
| | Comorbidity | 1 | 2009 | 1635 | 0.060 |
Why?
| | Seafood | 1 | 2023 | 17 | 0.060 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 304 | 0.060 |
Why?
| | Blood Pressure | 2 | 2021 | 1735 | 0.060 |
Why?
| | Zoonoses | 1 | 2004 | 25 | 0.060 |
Why?
| | Bites and Stings | 1 | 2004 | 31 | 0.060 |
Why?
| | Cellulitis | 1 | 2004 | 48 | 0.060 |
Why?
| | Cats | 1 | 2004 | 208 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1198 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2512 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 106 | 0.050 |
Why?
| | Pilot Projects | 2 | 2018 | 1530 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 562 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 35 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 56 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 147 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 28 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 26 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 426 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 870 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 232 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 251 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 315 | 0.050 |
Why?
| | Glycerol | 1 | 2022 | 92 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1618 | 0.050 |
Why?
| | Smell | 1 | 2023 | 122 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 53 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 40 | 0.050 |
Why?
| | Macrophages | 2 | 2021 | 1333 | 0.050 |
Why?
| | Japan | 1 | 2021 | 105 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 369 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 116 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 205 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 574 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 443 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 364 | 0.050 |
Why?
| | Pigments, Biological | 1 | 2001 | 12 | 0.050 |
Why?
| | RNA, Archaeal | 1 | 2001 | 13 | 0.050 |
Why?
| | Diet, Reducing | 1 | 2021 | 84 | 0.050 |
Why?
| | Waist Circumference | 1 | 2021 | 130 | 0.050 |
Why?
| | Systole | 1 | 2021 | 190 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4824 | 0.050 |
Why?
| | Tight Junctions | 1 | 2021 | 72 | 0.050 |
Why?
| | Aerobiosis | 1 | 2020 | 21 | 0.050 |
Why?
| | Consensus Sequence | 1 | 2000 | 71 | 0.050 |
Why?
| | Microvessels | 1 | 2021 | 75 | 0.050 |
Why?
| | Acetylation | 1 | 2021 | 230 | 0.050 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 147 | 0.050 |
Why?
| | DNA, Fungal | 1 | 2000 | 70 | 0.050 |
Why?
| | Caloric Restriction | 1 | 2021 | 97 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 424 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 356 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 96 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 95 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1743 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 497 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 269 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 53 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 213 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 3520 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 151 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 69 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 128 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 373 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 629 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 112 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 298 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 159 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 174 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6780 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 209 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 381 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 30 | 0.040 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 104 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 134 | 0.040 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 2 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 58 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 190 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 48 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 5 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2020 | 485 | 0.040 |
Why?
| | Acute Disease | 2 | 2016 | 1016 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 502 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 117 | 0.040 |
Why?
| | Syndecan-1 | 1 | 2017 | 30 | 0.040 |
Why?
| | Magnesium | 1 | 1998 | 159 | 0.040 |
Why?
| | Powders | 1 | 2017 | 38 | 0.040 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.040 |
Why?
| | Mucus | 1 | 2017 | 57 | 0.040 |
Why?
| | Plasma Cells | 1 | 2017 | 60 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2018 | 409 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 457 | 0.040 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 90 | 0.040 |
Why?
| | Glucose | 1 | 2022 | 995 | 0.040 |
Why?
| | Prophages | 1 | 2016 | 4 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1233 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 24 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 444 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 80 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 63 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 205 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 785 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 37 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 6 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 61 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 14 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 130 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 254 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 20 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 23 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 763 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 253 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 5 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 654 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2848 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 21 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 742 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 30 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 150 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 256 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 126 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 57 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 863 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 25 | 0.030 |
Why?
| | North America | 1 | 2016 | 271 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 348 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 620 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 310 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 86 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 59 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 12 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 8 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 353 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 59 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 352 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 513 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 33 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 551 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 19 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 7 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1011 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 155 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 83 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 2 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 231 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 6 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 22 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 137 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 42 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 467 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 90 | 0.030 |
Why?
| | Methane | 1 | 2014 | 46 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 75 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 2015 | 143 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2026 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 29 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 55 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 330 | 0.030 |
Why?
| | Geography | 1 | 2014 | 197 | 0.030 |
Why?
| | Models, Animal | 1 | 2015 | 373 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 26 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 233 | 0.030 |
Why?
| | Sequence Deletion | 1 | 1994 | 178 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 607 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 273 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 474 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 322 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 330 | 0.030 |
Why?
| | New York City | 1 | 2013 | 78 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 177 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1706 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 423 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 1992 | 14 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 249 | 0.030 |
Why?
| | Endoscopy | 1 | 2015 | 277 | 0.030 |
Why?
| | Genes, Lethal | 1 | 1992 | 26 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 6 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 8 | 0.030 |
Why?
| | Peritonitis | 1 | 2013 | 80 | 0.030 |
Why?
| | Staphylococcus | 1 | 2013 | 69 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 454 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2806 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 263 | 0.030 |
Why?
| | Down-Regulation | 1 | 2015 | 652 | 0.030 |
Why?
| | Antigens, CD | 1 | 2015 | 466 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 414 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2577 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 740 | 0.030 |
Why?
| | Cattle | 2 | 2005 | 1010 | 0.030 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.030 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 170 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 334 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 394 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 37 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1561 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 354 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 552 | 0.030 |
Why?
| | Signal Transduction | 2 | 2015 | 4809 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 429 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 94 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 379 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 445 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1210 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 579 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 749 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 298 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2008 | 0.020 |
Why?
| | Milk | 1 | 2012 | 133 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 141 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 406 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3152 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 797 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 109 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 437 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3274 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2580 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 654 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 327 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 569 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 266 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1233 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 243 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 421 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1093 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 830 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 7 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 23 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1366 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 43 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 15 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3309 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 202 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1373 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2098 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1642 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 419 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1241 | 0.020 |
Why?
| | RNA | 1 | 2013 | 875 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 884 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 24 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1046 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 641 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 471 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2333 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2005 | 159 | 0.020 |
Why?
| | Culture Media | 1 | 2005 | 164 | 0.020 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 12 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2016 | 2325 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 101 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 128 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 288 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 861 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 93 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 293 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1006 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1200 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1885 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 464 | 0.010 |
Why?
| | United States | 1 | 2015 | 13613 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 52 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 186 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 61 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 25 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 52 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 183 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1680 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 459 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4159 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 40 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 25 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 85 | 0.010 |
Why?
| | Genes | 1 | 1989 | 237 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 315 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1327 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|